← Back to Search

Aerobic Plus Resistance Training Group for Insulin Resistance (ARTIIS Trial)

N/A
Waitlist Available
Led By Robert L. Newton, PhD
Research Sponsored by Pennington Biomedical Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks
Awards & highlights

ARTIIS Trial Summary

The purpose of this study is to investigate the effect of an exercise training intervention on the ability of African American males to use insulin properly. Insulin is a hormone that helps the body use glucose.

Eligible Conditions
  • Insulin Resistance
  • Type 2 Diabetes

ARTIIS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in insulin response to an oral glucose tolerance test over 5 months.
Secondary outcome measures
Blood Pressure
Cardiorespiratory Fitness Testing
Dual Energy X-ray Absorptiometry (DEXA)
+4 more

ARTIIS Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Aerobic Plus Resistance Training GroupExperimental Treatment1 Intervention
We will randomly assign 52 individuals to an aerobic plus resistance training group.
Group II: Control GroupPlacebo Group1 Intervention
We will randomly assign 52 individuals to a no exercise healthy living group.

Find a Location

Who is running the clinical trial?

Pennington Biomedical Research CenterLead Sponsor
304 Previous Clinical Trials
181,323 Total Patients Enrolled
25 Trials studying Insulin Resistance
620 Patients Enrolled for Insulin Resistance
Robert L. Newton, PhDPrincipal InvestigatorPennington Biomedical Research Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025